Bruce D. Weintraub
Vorstandsvorsitzender bei Trophogen, Inc.
Aktive Positionen von Bruce D. Weintraub
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Vorstandsvorsitzender | 01.07.2001 | - |
Gründer | 25.02.2010 | - | |
Präsident | 01.07.2001 | - | |
Geschäftsführer | 01.07.2001 | 21.01.2013 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.07.2001 | 21.01.2013 |
Karriereverlauf von Bruce D. Weintraub
Ehemalige bekannte Positionen von Bruce D. Weintraub
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Maryland | Corporate Officer/Principal | 01.01.1996 | 01.01.2001 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
The Endocrine Society | Corporate Officer/Principal | - | - |
Ausbildung von Bruce D. Weintraub
Princeton University | Undergraduate Degree |
Harvard University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
The Endocrine Society |
- Börse
- Insiders
- Bruce D. Weintraub
- Erfahrung